News
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
Venetoclax demonstrated impressive efficacy in octogenarians with CLL, although treatment management posed some challenges.
4d
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
Learn how first-line antiepileptic drugs, personalized care, and lifestyle changes work together to manage generalized ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results